Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Jounce Therapeutics, Inc. (JNCE) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2023 4 Concentra Biosciences, LLC (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Acquired 10,000 shares @ $9737.7, valued at $97.4M
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Kamen Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Unknown transaction of 60,975 shares @ $0
Unknown transaction of 33,875 shares @ $0
Disposed/sold 10,840 options to buy @ $9.56, valued at $103.6k
Disposed/sold 13,550 options to buy @ $7.92, valued at $107.3k
Disposed/sold 15,700 options to buy @ $4.46, valued at $70k
Disposed/sold 15,700 options to buy @ $7.58, valued at $119k
Disposed/sold 15,700 options to buy @ $7.27, valued at $114.1k
Disposed/sold 20,000 options to buy @ $2.8, valued at $56k
05/04/2023 4 Iannone Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Disposed/sold 31,400 options to buy @ $7.19, valued at $225.8k
Disposed/sold 7,850 options to buy @ $7.58, valued at $59.5k
Disposed/sold 15,700 options to buy @ $7.27, valued at $114.1k
Disposed/sold 20,000 options to buy @ $2.8, valued at $56k
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Diaz Luis (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Disposed/sold 27,100 options to buy @ $14.78, valued at $400.5k
Disposed/sold 10,163 options to buy @ $7.92, valued at $80.5k
Disposed/sold 15,700 options to buy @ $4.46, valued at $70k
Disposed/sold 15,700 options to buy @ $7.58, valued at $119k
Disposed/sold 15,700 options to buy @ $7.27, valued at $114.1k
Disposed/sold 20,000 options to buy @ $2.8, valued at $56k
04/06/2023 4 MURRAY RICHARD /CA/ (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 39,228 shares @ $1.85, valued at $72.6k
03/14/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Bought 65,701 shares @ $0.994, valued at $65.3k
Bought 20,286 shares @ $1.018, valued at $20.7k
03/14/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on Jounce Therapeutics, Inc.
01/11/2023 4 Trehu Elizabeth (Chief Medical Officer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 4,159 shares @ $1.1, valued at $4.6k
Sold 5,126 shares @ $1.12, valued at $5.7k
01/11/2023 4 MURRAY RICHARD /CA/ (CEO and President) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 20,191 shares @ $1.1, valued at $22.2k
Sold 24,879 shares @ $1.12, valued at $27.9k
01/11/2023 4 Drapkin Kimberlee C (CFO and Treasurer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 6,315 shares @ $1.1, valued at $6.9k
Sold 7,781 shares @ $1.12, valued at $8.7k
01/11/2023 4 Cole Hugh M (COO) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 7,452 shares @ $1.1, valued at $8.2k
Sold 9,182 shares @ $1.12, valued at $10.3k
08/03/2022 4 Cole Hugh M (COO) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 20,000 shares @ $0
Granted 40,000 options to buy @ $2.97, valued at $118.8k
06/28/2022 4 Salter-Cid Luisa (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.8, valued at $56k
06/28/2022 4 Raythatha Jigar (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.8, valued at $56k
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Kamen Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.8, valued at $56k
06/28/2022 4 Iannone Robert (Director) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.8, valued at $56k
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2022 4/A Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 85,000 options to buy @ $7.56, valued at $642.6k
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 MURRAY RICHARD /CA/ (CEO and President) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 87,500 shares @ $0
Granted 175,000 options to buy @ $7.56, valued at $1.3M
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2022 4 Trehu Elizabeth (Chief Medical Officer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Sold 3,005 shares @ $7.3, valued at $21.9k
Sold 5,378 shares @ $6.65, valued at $35.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy